Successful desensitization in a patient with metastatic colorectal cancer presenting with regorafenib-mediated fix drug eruption.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Works matching IS 03445704 AND DT 2024 AND VI 94 AND IP 6
Results: 7
1
2
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 6, p. 799, doi. 10.1007/s00280-024-04717-w
- By:
- Publication type:
- Article
3
Retraction Note: NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
4
Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 6, p. 763, doi. 10.1007/s00280-024-04716-x
- By:
- Publication type:
- Article
5
Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 6, p. 787, doi. 10.1007/s00280-024-04714-z
- By:
- Publication type:
- Article
6
Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 6, p. 775, doi. 10.1007/s00280-024-04713-0
- By:
- Publication type:
- Article
7
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 6, p. 807, doi. 10.1007/s00280-024-04711-2
- By:
- Publication type:
- Article